2026-01-24 - Analysis Report
**Financial Report on IBM (2023-2025)**

**Company Overview**
IBM is a technology and consulting firm that has been a leader in the IT sector for decades.

**Return Rate Comparison**
The cumulative return of IBM is 151.48%, exceeding the cumulative return of the S&P 500 (VOO) by 25.10% on the last day of the data. This indicates a high degree of divergence between the two stocks.

**Alpha and Beta Analysis**
| Year       | Cumulative Return | Alpha | Beta         |
|------------|------------------|-------|--------------|
| 2016-2018  | -11.0%            | -23.0%| 101.6B       |
| 2017-2019  | -19.0%            | -44.0%| 119.8B       |
| 2018-2020  | -11.0%            | -35.0%| 112.5B       |
| 2019-2021  | 19.0%             | -46.0%| 124.9B       |
| 2020-2022  | 17.0%             | 11.0% | 131.7B       |
| 2021-2023  | 53.0%             | 33.0% | 152.9B       |
| 2022-2024  | 81.0%             | 51.0% | 205.5B       |
| 2023-2025  | 137.0%            | 61.0% | 276.9B       |

The analysis shows high volatility in the alpha and beta values across different periods, suggesting that IBM's stock price has been influenced by various market and economic factors.

**Recent Stock Price Fluctuations**
| Metric      | Value      |
|-------------|------------|
| Close       | $292.44    |
| Last-Market | -$0.76 (0.26%) |
| 5-day SMA   | $296.33    |
| 20-day SMA  | $300.51    |
| 60-day SMA  | $303.56    |

The 5-day SMA is slightly lower than the current stock price, indicating a slight decrease in the short-term trend. The 20-day and 60-day SMAs are above the current stock price, suggesting a potential upward trend in the medium- and long-term.

**RSI and PPO Index Indicators**
* RSI: 50.51
* PPO: -0.35

The RSI indicator is at a neutral level, suggesting that the stock price is not overbought or oversold. The PPO indicator is negative, indicating a potential drop in the stock price.

**Risk Level and Expected Return**
Risk Level: Medium (MRI: 0.70)
Expected Return: -5.90%

The MRI indicates a medium level of risk. The expected return is negative, suggesting that the stock price is expected to decline in the long term.

**Recent News and Significant Events (2026-01-23)**
* IBM (NYSE: IBM) Stock Deep Dive: The Blue Renaissance and the AI-Consulting Powerhouse - FinancialContent
* Forget Quantum Computing Stock: Buy This Dividend-Paying Quantum Pioneer, And Never Sell - The Motley Fool
* Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
* Opinions: 19
* Target Price (avg/high/low): 305.16 / 375.00 / 210.00

The news and analyst consensus suggest a positive outlook for IBM, with a target price above the current stock price.

**Earnings Analysis**
| Quarter | EPS | Revenue (B$) |
|---------|-----|--------------|
| 2025-10-23 | 1.87 | 16.33        |
| 2025-07-24 | 2.36 | 16.98        |
| 2025-04-24 | 1.14 | 14.54        |
| 2024-10-30 | -0.36 | 14.97        |
| 2025-10-23 | -0.36 | 14.97        |

The earnings analysis shows a mixed picture, with EPS and revenue fluctuating across different quarters. The revenue growth is moderate, while EPS is negative in some quarters.

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |

The revenue growth is moderate, with profit margins fluctuating across different quarters.

**Comprehensive Analysis**
IBM has shown strong growth in revenue and profit margins in some quarters, but with significant volatility in EPS. The stock price has been influenced by various market and economic factors, with a medium level of risk indicated by the MRI. The expected return is negative, suggesting that the stock price is expected to decline in the long term. However, the analyst consensus is positive, with a target price above the current stock price.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.